Gregg Nelson
@GreggNelsonERAS
Professor Gyn Oncology, Co-Chair Enhanced Recovery Canada, Harvard MPH Epi ‘26, #SocialMediaEditor @GynOncJnls
Risk for non-sentinel metastases in the contralateral groin in patients with unilateral positive sentinel lymph node in primary vulvar cancer @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
Chance of a lifetime 🚨 to be #SocialMediaEditor for @gynoncjnls 👏 please consider applying!! 🌟 🎆 sciencedirect.com/journal/gyneco…
Excited to talk about #ERAS #MIS in beautiful Strasbourg 🇫🇷 👏 🤖@socroboticsurg #SRS2025 @ErasSociety @ERAS_USA



Polycystic ovary syndrome and the risk of ovarian tumours @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
What better time to advance GYNOncology research? Amazing to connect and collaborate with so many great friends and colleagues!Inspirational talk by Dr Bert Vogelstein @SGO_org @GYNCancer @GOG #PathwaystoProgress
The SGO Pathways to Progress Summit is being held at Johns Hopkins today, bringing together global cancer care professionals, scientists, clinical trialists, patient advocates and community research partners to collaborate on strategies to advance gynecology oncology research.
NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
Granulosa cell tumor patients presenting with acute abdomen @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
Oncologic and fertility outcomes of progestin therapy for atypical hyperplasia and grade 1 cancer of the endometrium @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
Exacerbation of paraneoplastic cerebellar 🧠 degeneration by immune checkpoint inhibitor use in endometrial cancer @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
Evaluation of mutations detected in uterine exfoliated cells as a diagnostic tool for endometrial cancer @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
Missed opportunities: Germline testing following tumor sequencing @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
At WAGO meeting- in 2025, only 3.4% of NCI funding goes to funding gyn cancer research, despite endometrial cancer and ovarian cancer being 2 of the top 10 causes of cancer deaths. Endometrial cancer incidence and mortality is also increasing. We must change this.
Association between glucagon-like peptide-1 receptor agonists and ovarian cancer survival @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
REACT bowel REcovery after CyToreductive surgery for advanced ovarian cancer #LARS #LowAnteriorResectionSyndrome @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
AJOG Expert Review: Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society recommendations (part 2)—2025 update ow.ly/ISxw50W9xLx
So proud of my son Jack who graduated from @UCalgary today with BSc in Astrophysics! 🚀 🪐 ✨

Evaluation of mutations detected in uterine exfoliated cells as a diagnostic tool for endometrial cancer @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
Honored to speak about #ERAS to #MassGeneralBrigham #GynOnc divisions tonight! Thanks for the invitation! 👏 @MassGeneralNews @harvardmed @AriadneLabs @ErasSociety @ERAS_USA


Postoperative hypofractionated intensity-modulated radiation ☢️ therapy in cervical cancer @SGO_org @IGCSociety @ESGO_society @OncoAlert sciencedirect.com/science/articl…